Case 06: Esophageal Cancer to Metastasis to the Intra-abdominal Lymph Nodes
Treatment Performed
“Combined immunotherapy for cancer” was performed for an esophageal cancer with metastasis to the intra-abdominal lymph nodes, by combining the cancer peptide vaccine therapy and a drug to inhibit immunosuppression.
Treatment Outcome
Permanent cure with tumor disappearance
Before treatment
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_01.png)
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_02.png)
After treatment
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_03.png)
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_04.png)
Before treatment
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_001-1.png)
2 months after treatment initiation
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_002-1.png)
8 months after treatment initiation
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_003-1.png)
11 months after treatment initiation
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_004-1.png)
50 months after treatment initiation
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/08/06_005.png)
The level of killer T cells prominently increased, and the lymphocytes in the blood showed a strong immune response to cancer antigens.
![](https://neoclinic-en.jp/wp/wp-content/uploads/2021/12/case06.png)